EUVIMEDEUVIMED entdecken
EditorialOpen Access

The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation

Yun-Sang Lee iD

Nuclear Medicine and Molecular Imaging · 2026-06 · 60 (3) · 155-156

DOI: 10.1007/s13139-026-01019-2 ↗

Kurz gefasst

Editorial in der Zeitschrift Nuclear Medicine and Molecular Imaging, online erschienen am 25.04.2026. Verfasst von Yun-Sang Lee. Beteiligte Einrichtung: Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080 Republic of Korea. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080 Republic of Korea.

ORCID-Profile: Yun-Sang Lee

Zitieren

APA

Lee, Y. S. (2026). The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation. Nuclear Medicine and Molecular Imaging, 60(3), 155-156. https://doi.org/10.1007/s13139-026-01019-2

Vancouver

Lee YS. The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation. Nuclear Medicine and Molecular Imaging. 2026;60(3):155-156. doi:10.1007/s13139-026-01019-2

BibTeX
@article{Lee2026,
  author = {Lee, Yun-Sang},
  title = {The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation},
  journal = {Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {60},
  number = {3},
  pages = {155--156},
  doi = {10.1007/s13139-026-01019-2}
}
Kostenlos starten →